Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Did The FDA Make A Mistake? Sarepta's Elevidys Approval Under Scrutiny
Via Benzinga
Topics Death
Tickers SRPT
Exposures Death Product Safety
Sarepta Therapeutics Is Already Down 84% This Year. And The Other Shoe Just Dropped.
Via Investor's Business Daily
Topics Death
Tickers SRPT
Exposures Death Product Safety
Glucotrack Announces Positive Results From Its Implantable Blood Glucose Monitor Study: Retail Sentiment Hits 3-Month High
Via Stocktwits
Tickers GCTK
Exposures Product Safety
Sarepta Stock Slumps After FDA Opens Probe Into Patient Death, Analyst Sounds Alarm
Via Stocktwits
Topics Artificial Intelligence Death
Tickers IJH SRPT VTI
Exposures Artificial Intelligence Death Product Safety
GeoVax Comments on FDA Approval of Keytruda(R) in Head and Neck Cancer, Underscoring Potential for Gedeptin(R) Combination Therapy
Via TheNewswire.com
Tickers GOVX
Exposures Product Safety
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Rocket Pharmaceuticals, Inc. (RCKT) Shareholders
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Rocket Pharmaceuticals, Inc. (RCKT) Shareholders
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
The 5 Most Interesting Analyst Questions From CONMED’s Q1 Earnings Call
Via StockStory
Topics Earnings Economy World Trade
Exposures Financial Product Safety Supply Chain
MDC Associates Expands MedTech Clinical Solutions to Accelerate Regulatory Success
Via Press Release Distribution Service
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Hims & Hers CEO Says 'No Way In Hell We're Gonna Cave On' Selling Compounded Obesity Drugs After Novo Nordisk Breakup
Via Stocktwits
Topics Law Enforcement Lawsuit
Tickers HIMS NVO
Exposures Financial Legal Product Safety
FDA Skips Advisory Committee For Capricor's Duchenne Cell Therapy
Via Benzinga
Tickers CAPR
Exposures Product Safety
Tesla Ordered By French Investigators To Stop ‘Deceptive’ Claims Or Face Fines: Report
Via Stocktwits
Topics Fraud
Tickers TSLA VOO VTI
Exposures Legal Product Safety
5 Insightful Analyst Questions From Repligen’s Q1 Earnings Call
Via StockStory
Topics Earnings World Trade
Exposures Financial Product Safety Tariff
Capricor Therapeutics Says FDA May Not Hold Advisory Committee Meeting For DMD Therapy Approval: Stock Soars But Analyst Issues Warning
Via Stocktwits
Tickers CAPR VTI XBI
Exposures Product Safety
Memories.ai Unveils Human-Like Memory for AI, Revolutionizing Visual Understanding
Via Press Advantage
Topics Artificial Intelligence Product Recall
Exposures Artificial Intelligence Legal Product Safety
Cuban Guitarist Laura Mazon Franqui Signs with Prima Classic for Debut Album
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Revolution Medicines To Get Up To $2B For Development Of Cancer Drug From Royalty Pharma
Via Stocktwits
Tickers RPRX RVMD VTI
Exposures Product Safety
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
Rocket Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Rocket Pharmaceuticals, Inc. Class Action: Levi &amp; Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
GeoVax Comments on FDA Approval of Keytruda(R) in Head and Neck Cancer, Underscoring Potential for Gedeptin(R) Combination Therapy
Via NewMediaWire
Tickers GOVX
Exposures Product Safety
Axim Biotechnologies Files Pre-Submission With FDA for CLIA Waiver Pathway on Lactoferrin Point-of-Care Diagnostic Test
Via NewMediaWire
Tickers AXIM
Exposures Product Safety
Uber, Waymo Launch Robotaxis In Atlanta As Autonomous Ride-Hailing Competition Intensifies After Tesla KIcks Off Pilot
Via Stocktwits
Topics Electric Vehicles Product Recall
Tickers F GOOG GOOGL TSLA
Exposures Electric Vehicles Legal Product Safety
Ford Recalls Nearly 133,000 Lincoln Aviators In US Over Concerns Of Vehicle Parts Detaching
Via Stocktwits
Topics Product Recall
Tickers AMD F SCHD VTI
Exposures Legal Product Safety
Medicus Pharma Ltd. (NASDAQ:MDCX): Novel Treatment For Basal Cell Carcinoma Could Upend The $15 Billion Market
Via AB Newswire
Tickers MDCX
Exposures Product Safety
Medicus Pharma Ltd. (NASDAQ:MDCX): Novel Treatment For Basal Cell Carcinoma Could Upend The $15 Billion Market
Via News Direct
Tickers MDCX
Exposures Product Safety
FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For EGFR-Mutated Lung Cancer
Via Benzinga
Tickers AZN DSKYF DSNKY
Exposures Product Safety
Ford Recalls Aviator SUVs As Adhesive Issue Adds To Automaker's Mounting Recall Woes
Via Benzinga
Topics Product Recall
Tickers F
Exposures Legal Product Safety
Theodent Secures FDA 510(k) Clearance For Rennou Varnish, The First Fluoride-Free Professional Dental Varnish
Via Press Release Distribution Service
Exposures Product Safety
Eyenovia Climbs After-Hours On Revealing $50M Crypto Play And Validator Node Plans
Via Stocktwits
Tickers EYEN
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.